Eli Lilly and Company
LYSOPHOSPHATIDIC ACID RECEPTOR 1 (LPAR1) INHIBITOR COMPOUNDS
Last updated:
Abstract:
The present invention provides a compound of formula ##STR00001## or a pharmaceutical salt thereof, use, methods for its preparation are described.
Status:
Application
Type:
Utility
Filling date:
18 May 2022
Issue date:
8 Sep 2022